Bigul

Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended December 31,2019

We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31,2019 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31,2019; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31,2019 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.
07-02-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended December 31,2019

We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31,2019 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31,2019; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31,2019 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.
07-02-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Results - Unaudited Financial Results For Quarter Ended December 31, 2019

We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31,2019 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31,2019; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31,2019 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.
07-02-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment.
31-01-2020
Bigul

Merck announces an investment of $250 million in new facility in Switzerland

Merck, a science and technology company, has announced an investment of $250 million in a new facility in Corsier-sur-Vevey, Switzerland. The facility
28-01-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We have been informed by the shareholder, about the loss / misplacement of the share certificate as detailed in the attachment.
24-01-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Compliance Certificate Under Reg. 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Period Ended December 31, 2019

With reference to the above, we are enclosing herewith compliance certificate as per Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period ended December 31, 2020.
23-01-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We have been informed by the shareholder, about the loss / misplacement of the share certificate as detailed in the attachment.
22-01-2020
Bigul

Merck launches mobile primary health, palliative care unit in Kolkata

Merck, a science and technology company, in association with Global Cancer Concern India (GCCI), has launched a mobile primary health, cancer screenin
16-01-2020
Bigul

Procter & Gamble Health Ltd - 500126 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

We are enclosing herewith certificate under Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for the period ended December 31, 2019.
15-01-2020
Next Page
Close

Let's Open Free Demat Account